329788-70-7

Basic information

• Product Name: Cyclohexanemethanol, 4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 4-methylbenzenesulfonate, trans-
• CAS NO: 329788-70-7
• Molecular Formula: C21H36O4SSi
• Molecular Weight: 412.666
• Mol File: 329788-70-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Cyclohexanemethanol, 4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 4-methylbenzenesulfonate, trans-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanemethanol, 4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 4-methylbenzenesulfonate, trans-(329788-70-7)
• EPA Substance Registry System: Cyclohexanemethanol, 4-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-, 4-methylbenzenesulfonate, trans-(329788-70-7)

Safety Data

• Hazardous Substances Data: 329788-70-7(Hazardous Substances Data)

Upstream product

• 18162-48-6 tert-butyldimethylsilyl chloride 
• 3236-48-4 trans-1,4-Cyclohexanedimethanol 
• 98-59-9 p-toluenesulfonyl chloride 
• 180046-62-2 (±)-trans-[4-({[tert-butyl(dimethyl)silyl]oxy}methyl)cyclohexyl]methanol 

Downstream Products

• 180046-64-4 C₁₅H₂₉NOSi 
• 250386-15-3 Apadenoson 
• 287179-85-5 (4-prop-2-ynylcyclohexyl)methyl acetate 
• 250682-80-5 4-prop-2-ynylcyclohexanecarboxylic acid 
• 250682-81-6 methyl 4-prop-2-ynylcyclohexanecarboxylate 
• 250682-79-2 (4-prop-2-ynylcyclohexyl)methanol 

Relevant articles and documents

TRICYCLIC MODULATORS OF TNF SIGNALING

The invention provides tricyclic heterocyclic compounds, pharmaceutically acceptable salts, prodrugs, biologically active metabolites, stereoisomers and isomers thereof wherein the variables are defined herein. The compounds of the invention may be useful for treating immunological and oncological conditions.

Amino acid salt catalyzed intramolecular Robinson annulation

The silica gel absorbed amino acid salt catalyzed asymmetric intramolecular Robinson annulation reaction has been developed; up to 97% ee was obtained with this readily recoverable organocatalyst. The Royal Society of Chemistry 2009.

Cyclic AMP-dependent inhibition of human neutrophil oxidative activity by substituted 2-propynylcyclohexyl adenosine A2A receptor agonists

1. Novel 2-propynylcyclohexyl-5′-N-ehtylcarboxamidoadenosines, trans-substituted in the 4-position of the cyclohexyl ring, were evaluated in binding assays to the four subtypes of adenosine receptors (ARs). Two esters, 4-{(3-[6-amino-9-(5-ethylcarbamoyl-3